Current pharmacological treatments for nicotine dependence
Data up to Jan 2025
Total Citations Per Year
Abstract
References (75)
The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
1991 • 10,143 citations
Book Reviews
1995 • 2,946 citations
A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation
1999 • 1,635 citations
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
1997 • 1,273 citations
Measures of abstinence in clinical trials: issues and recommendations
2003 • 1,037 citations
Smoking and Major Depression
1993 • 821 citations
Bupropion: a review of its mechanism of antidepressant activity.
1995 • 693 citations
Inhibition of monoamine oxidase B in the brains of smokers
1996 • 666 citations
The effectiveness of the nicotine patch for smoking cessation. A meta-analysis
1994 • 533 citations
Bupropion is a nicotinic antagonist.
2000 • 490 citations
Cellular and synaptic mechanisms of nicotine addiction
2002 • 430 citations
Brain monoamine oxidase A inhibition in cigarette smokers
1996 • 427 citations
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum
2002 • 400 citations
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
1998 • 400 citations
Cellular mechanisms of nicotine addiction
2001 • 396 citations
Recent Advances in the Pharmacotherapy of Smoking
1999 • 385 citations
Sex differences in nicotine effects and self-administration: Review of human and animal evidence
1999 • 384 citations
Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas
2003 • 363 citations
Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia
2000 • 354 citations
Nicotinic Receptors in the Brain Links between Molecular Biology and Behavior
2000 • 352 citations
Treatment of Tobacco Use and Dependence
2002 • 347 citations
Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation
2001 • 343 citations
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline
1996 • 318 citations
Epidemiology of tobacco use in the United States
2002 • 311 citations
Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats
1997 • 288 citations
Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
1999 • 280 citations
Nicotine as a modulator of behavior: beyond the inverted U
2003 • 254 citations
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone
1994 • 253 citations
Treating Tobacco Use and Dependence
2002 • 231 citations
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice
2003 • 214 citations
A Randomized Trial of Nortriptyline for Smoking Cessation
1998 • 199 citations
Psychological Intervention and Antidepressant Treatment in Smoking Cessation
2002 • 192 citations
Pharmacogenetic investigation of smoking cessation treatment
2002 • 181 citations
Influencing cigarette smoking with nicotine antagonists
1973 • 178 citations
Neuronal nicotinic receptors: from structure to function
2001 • 174 citations
A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*
1995 • 167 citations
Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
1998 • 161 citations
Antimicrobial peptides from animals: focus on invertebrates
2002 • 158 citations
Nicotine Inhaler and Nicotine Patch as a Combination Therapy for Smoking Cessation
2000 • 155 citations
Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors.
1996 • 149 citations
Nicotine–mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
1998 • 141 citations
Selective Antagonism at Dopamine D3 Receptors Prevents Nicotine-Triggered Relapse to Nicotine-Seeking Behavior
2003 • 140 citations
Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving
2003 • 138 citations
Doxepin as an adjunct to smoking cessation: a double-blind pilot study
1989 • 111 citations
A randomized trial of naltrexone for smoking cessation
1999 • 106 citations
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
2003 • 104 citations
Naloxone Challenge in Smokers
1999 • 104 citations
Endogenous opioids and smoking: A review of progress and problems
1998 • 103 citations
The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control
2001 • 102 citations
Naltrexone, smoking behaviour and cigarette withdrawal
1995 • 101 citations
Antidepressant pharmacotherapy helps some cigarette smokers more than others.
1999 • 98 citations
BACLOFEN ANTAGONIZES INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN MICE AND RATS
2002 • 97 citations
The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials
2003 • 94 citations
A meta‐analysis of double‐blind placebo‐controlled trials of clonidine for smoking cessation
1991 • 92 citations
The future of smoking cessation therapy in the United States
1996 • 90 citations
The effects of fluoxetine combined with nicotine inhalers in smoking cessation‐a randomized trial
1999 • 90 citations
Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.
2002 • 87 citations
Nicotine patch and paroxetine for smoking cessation.
2000 • 87 citations
Antidepressant pharmacotherapy helps some cigarette smokers more than others.
1999 • 83 citations
Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
1994 • 80 citations
Naltrexone and nicotine patch in smoking cessation: A preliminary study
2003 • 75 citations
Is Clonidine an Effective Smoking Cessation Therapy?
1995 • 71 citations
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline
1996 • 66 citations
The future of smoking cessation therapy in the United States
1996 • 59 citations
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome
2001 • 58 citations
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
2000 • 57 citations
Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking
2001 • 52 citations
Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking
2001 • 52 citations
Efficacy of buspirone in smoking cessation: A placebo-controlled trial*
1996 • 45 citations
Naltrexone treatment for alcoholics: Effect on cigarette smoking rates
2003 • 40 citations
Nicotinic receptor blockade therapy and smoking cessation
1991 • 35 citations
Clonidine for smoking cessation
1999 • 29 citations
Transdermal clonidine for smoking cessation: A double-blind randomized dose–response study.
1996 • 19 citations
Clonidine for smoking cessation.
1998 • 14 citations
GlaxoSmithKline takes legal action to block new controls on its smoking cessation drug
2003 • 2 citations
Cited By (0)
No citing papers found in database